Pfizer to Seek Approval for COVID Vaccine Within Days After Final Analysis Shows it’s 95 Percent Effective with No Serious Side Effects
Pfizer announced Wednesday morning that it would seek approval for its COVID vaccine within days after a final analysis showed better results than those reported last week.
NBC News reports: “The U.S. pharma giant and its German partner said their Phase 3 trial was now complete, and that it found the vaccine was 95 percent effective at preventing symptomatic Covid-19 — up from the 90 percent announced last week. There have been no serious side effects among the 41,135 adults who received two doses, the companies said in a joint statement. The most common reactions were that 3.7 percent of participants experiencing fatigue and 2 percent had a headache, it said.”
“Their vaccine has been tested on 43,500 people in six countries and no safety concerns have been raised,” BBC reported last
Live Guys Online Now!